Two-Year Clinical Response to Brodalumab, an Anti-Interleukin-17 Receptor Antibody, in Patients with Psoriatic Arthritis Genovese, M. C., Mease, P. J., Greenwald, M., Ritchlin, C. T., Beaulieu, A., Deodhar, A. A., Newmark, R., Feng, J., Erondu, N., Nirula, A. WILEY-BLACKWELL. 2015

View details for Web of Science ID 000370860204422